Pemoline

"Pemoline" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A central nervous system stimulant used in fatigue and depressive states and to treat hyperkinetic disorders in children.

Descriptor ID

D010389

MeSH Number(s)

D03.383.129.462.673

Concept/Terms

Below are MeSH descriptors whose meaning is more general than "Pemoline".

Chemicals and Drugs [D]
Heterocyclic Compounds [D03]
Heterocyclic Compounds, 1-Ring [D03.383]
Azoles [D03.383.129]
Oxazoles [D03.383.129.462]
Pemoline [D03.383.129.462.673]

Below are MeSH descriptors whose meaning is related to "Pemoline".

Below are MeSH descriptors whose meaning is more specific than "Pemoline".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Pemoline" by people in Harvard Catalyst Profiles by year, and whether "Pemoline" was a major or minor topic of these publication.

Bar chart showing 10 publications over 8 distinct years, with a maximum of 2 publications in 2000 and 2005

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1995	1	0	1
1998	0	1	1
1999	1	0	1
2000	2	0	2
2002	0	1	1
2004	0	1	1
2005	0	2	2
2010	0	1	1

Below are the most recent publications written about "Pemoline" by people in Profiles.

Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proc Natl Acad Sci U S A. 2010 Sep 28; 107(39):16970-5.

View in: PubMed
Treatment of attention-deficit/hyperactivity disorder: overview of the evidence. Pediatrics. 2005 Jun; 115(6):e749-57.

View in: PubMed
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder. J Clin Psychiatry. 2005 Feb; 66(2):253-9.

View in: PubMed
Stimulant treatment of adult attention-deficit/hyperactivity disorder. Psychiatr Clin North Am. 2004 Jun; 27(2):361-72.

View in: PubMed
Drug-attributed hepatic failure: causality, risk assessment, consent, and confusion. J Clin Psychopharmacol. 2003 Dec; 23(6):533-4.

View in: PubMed
Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002 Feb; 41(2 Suppl):26S-49S.

View in: PubMed
Severe hypotension in a patient receiving pemoline during general anesthesia. Anesth Analg. 2000 Nov; 91(5):1131-3.

View in: PubMed
Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial. J Child Adolesc Psychopharmacol. 2000; 10(3):205-16.

View in: PubMed
Controlled trial of high doses of pemoline for adults with attention-deficit/hyperactivity disorder. J Clin Psychopharmacol. 1999 Jun; 19(3):257-64.

View in: PubMed
Dopaminergic agents and stimulants as antidepressant augmentation strategies. J Clin Psychiatry. 1998; 59 Suppl 5:60-3; discussion 64.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

J Clin Psychopharmacol
J Child Adolesc Psychopharmacol
Int Clin Psychopharmacol
Drug Alcohol Depend
Dev Neurosci
Anesth Analg
Am J Gastroenterol
J Clin Psychiatry
Pediatrics
J Am Acad Child Adolesc Psychiatry